<?xml version="1.0" encoding="UTF-8"?>
<p>Respiratory syncytial virus is the most commonly identified cause of acute lower respiratory tract infection in infants, children, immunocompromised adults, and the elderly (
 <xref rid="ref172" ref-type="bibr">Zorc and Hall, 2010</xref>; 
 <xref rid="ref58" ref-type="bibr">Griffiths et al., 2017</xref>). Since the first isolation of the virus from chimpanzees in 1956 (
 <xref rid="ref102" ref-type="bibr">Morris et al., 1956</xref>), extensive research has been conducted in epidemiology, diagnosis, and animal models for the infection, but there is no vaccine and only two approved antivirals available against the virus (
 <xref rid="ref166" ref-type="bibr">Xing and Proesmans, 2019</xref>).
</p>
